Dermoscopy for the pediatric dermatologist, part II: Dermoscopy of genetic syndromes with cutaneous manifestations and pediatric vascular lesions

Pediatric Dermatology

Volumn 30, Issue 2, 2013, Pages 172-181

  Haliasos, Elena C ^a   Kerner, Miryam ^b   Jaimes, Natalia ^b   Zalaudek, Iris ^c   Malvehy, Josep ^d   Lanschuetzer, Christoph M ^e   Hinter, Helmut ^e   Hofmann Wellenhof, Rainer ^c   Braun, Ralph P ^f   Marghoob, Ashfaq A ^b  

^a Private Practice   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d HOSPITAL CLÍNIC   (Spain)

^e PARACELSUS MEDICAL UNIVERSITY   (Austria)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; PROTEIN PATCHED;

ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; BOWEN DISEASE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SUSCEPTIBILITY; CAPILLARY HEMANGIOMA; CHILD; CLINICAL FEATURE; CONGENITAL BLOOD VESSEL MALFORMATION; CUTANEOUS LYMPHANGIOMA CIRCUMSCRIPTUM; DERMATOLOGIST; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; EPIDERMODYSPLASIA VERRUCIFORMIS; EPIDERMOLYSIS BULLOSA; EPILUMINESCENCE MICROSCOPY; GENE MUTATION; GENETIC DISORDER; HEMANGIOMA; HISTOPATHOLOGY; HUMAN; LYMPHANGIOMA; MALIGNANT TRANSFORMATION; MELANOCYTIC NEVUS; MELANOMA; NEVUS FLAMMEUS; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PYOGENIC GRANULOMA; RADIATION EXPOSURE; RADIATION PROTECTION; SKIN BLOOD VESSEL; SKIN CANCER; SKIN CARCINOMA; SKIN EXAMINATION; SKIN MANIFESTATION; SKIN PROTECTION; TINEA VERSICOLOR; TOPICAL TREATMENT; TUMOR VASCULARIZATION; VASCULAR LESION; VASCULAR TUMOR; XERODERMA PIGMENTOSUM;

BASAL CELL NEVUS SYNDROME; CHILD; DERMOSCOPY; DIAGNOSIS, DIFFERENTIAL; EPIDERMODYSPLASIA VERRUCIFORMIS; EPIDERMOLYSIS BULLOSA; HUMANS; PHYSICIANS; SKIN DISEASES, GENETIC; SKIN DISEASES, VASCULAR; SKIN NEOPLASMS; XERODERMA PIGMENTOSUM;

EID: 84874937674     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2012.01874.x     Document Type: Article

References (47)

1. Rosendahl C, Tschandl P, Cameron A, et al. Diagnostic accuracy of dermatoscopy for melanocytic and nonmelanocytic pigmented lesions. J Am Acad Dermatol 2011; 64: 1068-1073.
2. Gorlin RJ, Goltz RW,. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. N Engl J Med 1960; 262: 908-912.
3. Farndon PA, Del Mastro RG, Evans DG, et al. Location of gene for Gorlin syndrome. Lancet 1992; 339: 581-582.
4. Kolm I, Puig S, Iranzo P, et al. Dermoscopy in Gorlin-Goltz syndrome. Dermatol Surg 2006; 32: 847-851.
5. Peris K, Altobelli E, Ferrari A, et al. Interobserver agreement on dermoscopic features of pigmented basal cell carcinoma. Dermatol Surg 2002; 28: 643-645.
6. Giacomel J, Zalaudek I,. Dermoscopy of superficial basal cell carcinoma. Dermatol Surg 2005; 31: 1710-1713.
7. Menzies SW, Westerhoff K, Rabinovitz H, et al. Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol 2000; 136: 1012-1016.
8. Liebman TN, Lopez NJ, Balagula Y, et al. Dermoscopic features of basal cell carcinomas: differences in appearance under non-polarized and polarized light. Dermatol Surg 2012; 38: 392-399.
9. Liebman TN, Rabinovitz HS, Dusza SW, et al. White shiny structures: dermoscopic features revealed under polarized light. J Eur Acad Dermatol Venereol 2011 Oct 31. doi: 10.1111/j.1468-3083.2011.04317.x [Epub ahead of print].
10. Benvenuto-Andrade C, Dusza SW, Agero AL, et al. Differences between polarized light dermoscopy and immersion contact dermoscopy for the evaluation of skin lesions. Arch Dermatol 2007; 143: 329-338.
11. Tiodorovic-Zivkovic D, Zalaudek I, Ferrara G, et al. Clinical and dermatoscopic findings in Bazex-Dupre-Christol and Gorlin-Goltz syndromes. J Am Acad Dermatol 2010; 63: 722-724.
12. Micantonio T, Fargnoli MC, Piccolo D, et al. Letter: changes in dermoscopic features in superficial basal cell carcinomas treated with imiquimod. Dermatol Surg 2007; 33: 1403-1405.
13. Peris K, Ferrari A, Fargnoli MC, et al. Dermoscopic monitoring of tazarotene treatment of superficial basal cell carcinoma. Dermatol Surg 2005; 31: 217-220.
14. Peris K, Campione E, Micantonio T, et al. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial. Dermatol Surg 2005; 31: 318-323.
15. Kraemer KH, Lee MM, Andrews AD, et al. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 1994; 130: 1018-1021.
16. Malvehy J, Puig S, Marti-Laborda RM,. Dermoscopy of skin lesions in two patients with xeroderma pigmentosum. Br J Dermatol 2005; 152: 271-278.
17. Green WH, Wang SQ, Cognetta AB Jr,. Total-body cutaneous examination, total-body photography, and dermoscopy in the care of a patient with xeroderma pigmentosum and multiple melanomas. Arch Dermatol 2009; 145: 910-915.
18. Vazquez-Lopez F, Kreusch J, Marghoob AA,. Dermoscopic semiology: further insights into vascular features by screening a large spectrum of nontumoral skin lesions. Br J Dermatol 2004; 150: 226-231.
19. Zalaudek I, Argenziano G, Leinweber B, et al. Dermoscopy of Bowen's disease. Br J Dermatol 2004; 150: 1112-1116.
20. Jablonska S, Dabrowski J, Jakubowicz K,. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 1972; 32: 583-589.
21. Padlewska K, Ramoz N, Cassonnet P, et al. Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis. J Invest Dermatol 2001; 117: 935-942.
22. Segura S, Carrera C, Ferrando J, et al. Dermoscopy in epidermodysplasia verruciformis. Dermatol Surg 2006; 32: 103-106.
23. Uitto J, Richard G,. Progress in epidermolysis bullosa: from eponyms to molecular genetic classification. Clin Dermatol 2005; 23: 33-40.
24. Bauer JW, Schaeppi H, Kaserer C, et al. Large melanocytic nevi in hereditary epidermolysis bullosa. J Am Acad Dermatol 2001; 44: 577-584.
25. Lanschuetzer CM, Laimer M, Nischler E, et al. Epidermolysis bullosa nevi. Dermatol Clin 2010; 28: 179-183.
26. Gallardo F, Toll A, Malvehy J, et al. Large atypical melanocytic nevi in recessive dystrophic epidermolysis bullosa: clinicopathological, ultrastructural, and dermoscopic study. Pediatr Dermatol 2005; 22: 338-343.
27. Cash SH, Dever TT, Hyde P, et al. Epidermolysis bullosa nevus: an exception to the clinical and dermoscopic criteria for melanoma. Arch Dermatol 2007; 143: 1164-1167.
28. Soltani K, Pepper MC, Simjee S, et al. Large acquired nevocytic nevi induced by the Koebner phenomenon. J Cutan Pathol 1984; 11: 296-299.
29. Lanschuetzer CM, Emberger M, Laimer M, et al. Epidermolysis bullosa naevi reveal a distinctive dermoscopic pattern. Br J Dermatol 2005; 153: 97-102.
30. Hoss DM, McNutt NS, Carter DM, et al. Atypical melanocytic lesions in epidermolysis bullosa. J Cutan Pathol 1994; 21: 164-169.
31. Goldberg GI, Eisen AZ, Bauer EA,. Tissue stress and tumor promotion. Possible relevance to epidermolysis bullosa. Arch Dermatol 1988; 124: 737-741.
32. Grubauer G, Hintner H, Klein G, et al. [Acquired, surface giant nevus cell nevi in generalized, atrophic, benign epidermolysis bullosa]. Hautarzt 1989; 40: 523-526.
33. McGrath JA, Schofield OM, Mayou BJ, et al. Epidermolysis bullosa complicated by squamous cell carcinoma: report of 10 cases. J Cutan Pathol 1992; 19: 116-123.
34. Paller A, Mancini A,. Vascular disorders of infancy and childhood. In:, Paller A, Mancini A, eds. Hurwitz clinical pediatric dermatology: a textbook of skin disorders of childhood and adolescence. Philadelphia: Elsevier Saunders, 2005: 307-344.
35. Zaballos P, Carulla M, Ozdemir F, et al. Dermoscopy of pyogenic granuloma: a morphological study. Br J Dermatol 2010; 163: 1229-1237.
36. Zaballos P, Llambrich A, Cuellar F, et al. Dermoscopic findings in pyogenic granuloma. Br J Dermatol 2006; 154: 1108-1111.
37. Zalaudek I, Kreusch J, Giacomel J, et al. How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part I. Melanocytic skin tumors. J Am Acad Dermatol 2010; 63: 361-374; quiz 375-366.
38. Oiso N, Kimura M, Kawara S, et al. Clinical, dermoscopic, and histopathologic features in a case of infantile hemangioma without proliferation. Pediatr Dermatol 2011; 28: 66-68.
39. Marghoob AA, Braun RP, Kopf AW,. Atlas of dermoscopy. Abingdon: Taylor and Francis, 2005.
40. Wang SQ, Katz B, Rabinovitz H, et al. Lessons on dermoscopy #7. The diagnosis was thrombosed hemangioma. Dermatol Surg 2000; 26: 891-892.
41. Sevila A, Nagore E, Botella-Estrada R, et al. Videomicroscopy of venular malformations (port-wine stain type): prediction of response to pulsed dye laser. Pediatr Dermatol 2004; 21: 589-596.
42. Vazquez-Lopez F, Manjon-Haces JA, Vazquez-Lopez AC, et al. The hand-held dermatoscope improves the clinical evaluation of port-wine stains. J Am Acad Dermatol 2003; 48: 984-985.
43. Motley RJ, Lanigan SW, Katugampola GA,. Videomicroscopy predicts outcome in treatment of port-wine stains. Arch Dermatol 1997; 133: 921-922.
44. Calonje E, Wilson-Jones E,. Vascular tumor. In:, Elder D, Elenitsas R, Jaworsky C, et al., eds. Lever's histopathology of the skin, 8th ed. Philadelphia: Lippincott-Raven, 1997: 921-923.
45. Amini S, Kim NH, Zell DS, et al. Dermoscopic-histopathologic correlation of cutaneous lymphangioma circumscriptum. Arch Dermatol 2008; 144: 1671-1672.
46. Arpaia N, Cassano N, Vena GA,. Dermoscopic features of cutaneous lymphangioma circumscriptum. Dermatol Surg 2006; 32: 852-854.
47. Wang LC, Krunic AL, Medenica MM, et al. Treatment of hemorrhagic lymphatic malformation of the tongue with a pulsed-dye laser. J Am Acad Dermatol 2005; 52: 1088-1090.